$164.52
Price
$255.2B
Market Cap
24.6
P/E Ratio
14.5
Forward P/E
$6.68
EPS (TTM)
1.92%
Dividend Yield
$5.0B
Cash
$29.1B
Total Debt
1.55B
Shares Out
$145.80
$212.71
52-Week Range
Institutional Ownership of Astrazeneca PLC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 9.4M | $1.8B | $189.03 | -12.97% |
Trading Activity for Astrazeneca PLC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| BUY | +26.1% | 9.4M | $1.8B | $185.65 | |
| 2026-Q1 | |||||
| BUY | NEW | 7.4M | $1.4B | $189.91 | |
| SELL | EXIT | — | — | $189.91 | |
| 2025-Q4 | |||||
| SELL | -5.3% | 1.0M | $93M | $88.68 | |
| 2025-Q3 | |||||
| BUY | +11.9% | 1.1M | $82M | $75.34 | |
| 2025-Q2 | |||||
| BUY | +11.1% | 953.4K | $67M | $70.07 | |
| 2025-Q1 | |||||
| BUY | +3.1% | 857.9K | $63M | $73.05 | |
| 2024-Q4 | |||||
| BUY | +69.6% | 831.9K | $55M | $67.20 | |
| 2024-Q3 | |||||
| BUY | +8.8% | 490.4K | $38M | $79.24 | |
| 2024-Q2 | |||||
| SELL | -9.2% | 450.6K | $35M | $76.97 | |
| 2024-Q1 | |||||
| BUY | +7.8% | 496.5K | $34M | $66.33 | |
| 2023-Q4 | |||||
| BUY | +29.7% | 460.7K | $31M | $64.28 | |
| 2023-Q3 | |||||
| BUY | +34.4% | 355.2K | $24M | $68.22 | |
| 2023-Q2 | |||||
| SELL | -18.3% | 264.3K | $19M | $73.85 | |
| 2023-Q1 | |||||
| BUY | +12.2% | 323.7K | $22M | $66.99 | |
| 2022-Q4 | |||||
| SELL | -5.2% | 288.6K | $20M | $63.95 | |
| 2022-Q3 | |||||
| SELL | -8.8% | 304.6K | $17M | $65.79 | |
| 2022-Q2 | |||||
| SELL | -18.2% | 333.9K | $22M | $66.19 | |
| 2022-Q1 | |||||
| BUY | +23.5% | 408.2K | $27M | $59.48 | |
| 2021-Q4 | |||||
| SELL | -4.8% | 330.5K | $19M | $58.80 | |
| 2021-Q3 | |||||
| BUY | +104.4% | 347.0K | $21M | $58.41 | |
| 2021-Q2 | |||||
| BUY | NEW | 169.8K | $10M | $55.55 | |
| 2020-Q3 | |||||
| SELL | EXIT | — | — | $55.71 | |
| 2020-Q2 | |||||
| SELL | -38.8% | 236.7K | $13M | $52.72 | |
| 2020-Q1 | |||||
| SELL | -17.4% | 386.6K | $17M | $48.90 | |
| 2019-Q4 | |||||
| SELL | -18.2% | 468.3K | $23M | $47.67 | |
| 2019-Q3 | |||||
| SELL | -32.7% | 572.4K | $26M | $43.86 | |
| 2019-Q2 | |||||
| BUY | +19.6% | 850.5K | $35M | $38.80 | |
| 2019-Q1 | |||||
| SELL | -3.3% | 711.2K | $29M | $39.98 | |
| 2018-Q4 | |||||
| SELL | -18.0% | 735.6K | $28M | $39.02 | |
| 2018-Q3 | |||||
| BUY | +0.3% | 897.4K | $36M | $37.96 | |
| 2018-Q2 | |||||
| BUY | +1.7% | 894.9K | $31M | $36.12 | |
| 2018-Q1 | |||||
| BUY | +8.1% | 879.9K | $31M | $34.57 | |
Insider Trading for Astrazeneca PLC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.